At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
AVTE Aerovate Therapeutics, Inc.
Closed 12-23 16:00:00 EST
2.56
+0.03
+1.19%
盘后2.49
-0.07-2.73%
18:26 EST
High2.59
Low2.53
Vol270.45K
Open2.53
D1 Closing2.53
Amplitude2.37%
Mkt Cap73.92M
Tradable Cap30.35M
Total Shares28.87M
T/O690.57K
T/O Rate2.28%
Tradable Shares11.85M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Calendar of U.S. Earnings Expected in the Week Ahead
Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. The company was incorporated in 2018 and is headquartered in Waltham, Massachusetts.